Drugs without GIPR activity (semaglutide, orforglipron, survodutide, pemvidutide) are plotted along the bottom axis
2003 , 6 , 4166 [3] Pooyandjoo, M
In their marketing, telehealth companies claim that compounded GLP-1s in small doses starting lower than FDA-approved doses from Novo Nordisk and Eli Lilly can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline
In head-to-head comparison during the STEP trials, semaglutide 2.4 mg weekly produced significantly greater weight reduction than liraglutide 3.0 mg daily, approximately 15% versus 7% of body weight over similar timeframes
Notably, there was no evidence that time-varying weight loss mediated the effect of semaglutide on MACE
It is either administered orally or through an injection process